Clinical trial
A Clinical Study to Determine the Optimal Dose of WIN-1001X by Evaluating Its Efficacy and Safety in Patients With Early Parkinson's Disease: Double-blind, Randomized, Placebo-controlled, Multicenter, Phase II Study
NCT04220762 is registered in ClinicalTrials.gov with Medi Help Line as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study to Determine the Optimal Dose of WIN-1001X by Evaluating Its Efficacy and Safety in Patients With Early Parkinson's Disease: Double-blind, Randomized, Placebo-controlled, Multicenter, Phase II Study
- Lead sponsor
- Medi Help Line
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 21, 2020
- Completion date
- September 30, 2021
- Enrollment
- 188 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.